EMEA (Europe, Middle East and Africa) Viral Molecular Diagnostics Market Report 2017

Table of Contents

EMEA (Europe, Middle East and Africa) Viral Molecular Diagnostics Market Report 2017
1 Viral Molecular Diagnostics Overview
1.1 Product Overview and Scope of Viral Molecular Diagnostics
1.2 Classification of Viral Molecular Diagnostics
1.2.1 EMEA Viral Molecular Diagnostics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Viral Molecular Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarrays
1.2.5 DNA Sequencing
1.3 EMEA Viral Molecular Diagnostics Market by Application/End Users
1.3.1 EMEA Viral Molecular Diagnostics Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hepatitis C virus (HCV)
1.3.3 Genetics
1.3.4 Blood Screening
1.4 EMEA Viral Molecular Diagnostics Market by Region
1.4.1 EMEA Viral Molecular Diagnostics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Viral Molecular Diagnostics (2012-2022)
1.5.1 EMEA Viral Molecular Diagnostics Sales and Growth Rate (2012-2022)
1.5.2 EMEA Viral Molecular Diagnostics Revenue and Growth Rate (2012-2022)

2 EMEA Viral Molecular Diagnostics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Viral Molecular Diagnostics Market Competition by Players/Manufacturers
2.1.1 EMEA Viral Molecular Diagnostics Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Viral Molecular Diagnostics Revenue and Share by Players (2012-2017)
2.1.3 EMEA Viral Molecular Diagnostics Sale Price by Players (2012-2017)
2.2 EMEA Viral Molecular Diagnostics (Volume and Value) by Type/Product Category
2.2.1 EMEA Viral Molecular Diagnostics Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Viral Molecular Diagnostics Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Viral Molecular Diagnostics Sale Price by Type (2012-2017)
2.3 EMEA Viral Molecular Diagnostics (Volume) by Application
2.4 EMEA Viral Molecular Diagnostics (Volume and Value) by Region
2.4.1 EMEA Viral Molecular Diagnostics Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Viral Molecular Diagnostics Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Viral Molecular Diagnostics Sales Price by Region (2012-2017)

3 Europe Viral Molecular Diagnostics (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Viral Molecular Diagnostics Sales and Value (2012-2017)
3.1.1 Europe Viral Molecular Diagnostics Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Viral Molecular Diagnostics Revenue and Growth Rate (2012-2017)
3.2 Europe Viral Molecular Diagnostics Sales and Market Share by Type
3.3 Europe Viral Molecular Diagnostics Sales and Market Share by Application
3.4 Europe Viral Molecular Diagnostics Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Viral Molecular Diagnostics Sales Volume by Countries (2012-2017)
3.4.2 Europe Viral Molecular Diagnostics Revenue by Countries (2012-2017)
3.4.3 Germany Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
3.4.4 France Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
3.4.5 UK Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
3.4.6 Russia Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
3.4.7 Italy Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
3.4.8 Benelux Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)

4 Middle East Viral Molecular Diagnostics (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Viral Molecular Diagnostics Sales and Value (2012-2017)
4.1.1 Middle East Viral Molecular Diagnostics Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Viral Molecular Diagnostics Revenue and Growth Rate (2012-2017)
4.2 Middle East Viral Molecular Diagnostics Sales and Market Share by Type
4.3 Middle East Viral Molecular Diagnostics Sales and Market Share by Application
4.4 Middle East Viral Molecular Diagnostics Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Viral Molecular Diagnostics Sales Volume by Countries (2012-2017)
4.4.2 Middle East Viral Molecular Diagnostics Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
4.4.4 Israel Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
4.4.5 UAE Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
4.4.6 Iran Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)

5 Africa Viral Molecular Diagnostics (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Viral Molecular Diagnostics Sales and Value (2012-2017)
5.1.1 Africa Viral Molecular Diagnostics Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Viral Molecular Diagnostics Revenue and Growth Rate (2012-2017)
5.2 Africa Viral Molecular Diagnostics Sales and Market Share by Type
5.3 Africa Viral Molecular Diagnostics Sales and Market Share by Application
5.4 Africa Viral Molecular Diagnostics Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Viral Molecular Diagnostics Sales Volume by Countries (2012-2017)
5.4.2 Africa Viral Molecular Diagnostics Revenue by Countries (2012-2017)
5.4.3 South Africa Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
5.4.5 Egypt Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)
5.4.6 Algeria Viral Molecular Diagnostics Sales and Growth Rate (2012-2017)

6 EMEA Viral Molecular Diagnostics Manufacturers/Players Profiles and Sales Data
6.1 Abbott Laboratories, Inc.(US)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bio-Rad Laboratories(US)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bio-Rad Laboratories(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Beckman Coulter(US)
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Beckman Coulter(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Auto Genomics Inc(US)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Auto Genomics Inc(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Becton, Dickinson and Company(US)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Becton, Dickinson and Company(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 F. Hoffmann-La Roche AG(Swizerland)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roche Diagnostics(US)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roche Diagnostics(US) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Olympus Corporation(Japan)
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Olympus Corporation(Japan) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi(China)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi(China) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 QIAGEN(Germany)
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Viral Molecular Diagnostics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 QIAGEN(Germany) Viral Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 bioMerieux SA(France)
6.12 Meridian Bioscience, Inc(US)
6.13 Gen-Probe Inc.(US)

7 Viral Molecular Diagnostics Manufacturing Cost Analysis
7.1 Viral Molecular Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Molecular Diagnostics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Viral Molecular Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Molecular Diagnostics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Viral Molecular Diagnostics Market Forecast (2017-2022)
11.1 EMEA Viral Molecular Diagnostics Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Viral Molecular Diagnostics Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Viral Molecular Diagnostics Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Viral Molecular Diagnostics Price and Trend Forecast (2017-2022)
11.2 EMEA Viral Molecular Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Viral Molecular Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Viral Molecular Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Viral Molecular Diagnostics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Viral Molecular Diagnostics Sales Forecast by Type (2017-2022)
11.7 EMEA Viral Molecular Diagnostics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Viral Molecular Diagnostics
Figure EMEA Viral Molecular Diagnostics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Viral Molecular Diagnostics Sales Volume Market Share by Type (Product Category) in 2016
Figure Polymerase Chain Reaction (PCR) Product Picture
Figure Microarrays Product Picture
Figure DNA Sequencing Product Picture
Figure EMEA Viral Molecular Diagnostics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Viral Molecular Diagnostics by Application in 2016
Figure Hepatitis C virus (HCV) Examples
Table Key Downstream Customer in Hepatitis C virus (HCV)
Figure Genetics Examples
Table Key Downstream Customer in Genetics
Figure Blood Screening Examples
Table Key Downstream Customer in Blood Screening
Figure EMEA Viral Molecular Diagnostics Market Size (Million USD) by Region (2012-2022)
Figure Europe Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Viral Molecular Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Viral Molecular Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Viral Molecular Diagnostics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Viral Molecular Diagnostics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Viral Molecular Diagnostics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales Share by Players (2012-2017)
Figure 2016 Viral Molecular Diagnostics Sales Share by Players
Figure 2017 Viral Molecular Diagnostics Sales Share by Players
Figure EMEA Viral Molecular Diagnostics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Viral Molecular Diagnostics Revenue (Million USD) by Players (2012-2017)
Table EMEA Viral Molecular Diagnostics Revenue Share by Players (2012-2017)
Table 2016 EMEA Viral Molecular Diagnostics Revenue Share by Players
Table 2017 EMEA Viral Molecular Diagnostics Revenue Share by Players
Table EMEA Viral Molecular Diagnostics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral Molecular Diagnostics by Type (2012-2017)
Figure EMEA Viral Molecular Diagnostics Sales Market Share by Type (2012-2017)
Table EMEA Viral Molecular Diagnostics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Viral Molecular Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Molecular Diagnostics by Type in 2016
Table EMEA Viral Molecular Diagnostics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral Molecular Diagnostics by Application (2012-2017)
Figure EMEA Viral Molecular Diagnostics Sales Market Share by Application in 2016
Table EMEA Viral Molecular Diagnostics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Viral Molecular Diagnostics Sales Share by Region (2012-2017)
Figure Sales Market Share of Viral Molecular Diagnostics by Region (2012-2017)
Figure EMEA Viral Molecular Diagnostics Sales Market Share in 2016
Table EMEA Viral Molecular Diagnostics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Viral Molecular Diagnostics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Viral Molecular Diagnostics by Region (2012-2017)
Figure EMEA Viral Molecular Diagnostics Revenue Market Share Regions in 2016
Table EMEA Viral Molecular Diagnostics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Viral Molecular Diagnostics Revenue and Growth Rate (2012-2017)
Table Europe Viral Molecular Diagnostics Sales (K Units) by Type (2012-2017)
Table Europe Viral Molecular Diagnostics Market Share by Type (2012-2017)
Figure Europe Viral Molecular Diagnostics Market Share by Type in 2016
Table Europe Viral Molecular Diagnostics Sales (K Units) by Application (2012-2017)
Table Europe Viral Molecular Diagnostics Market Share by Application (2012-2017)
Figure Europe Viral Molecular Diagnostics Market Share by Application in 2016
Table Europe Viral Molecular Diagnostics Sales (K Units) by Countries (2012-2017)
Table Europe Viral Molecular Diagnostics Sales Market Share by Countries (2012-2017)
Figure Europe Viral Molecular Diagnostics Sales Market Share by Countries (2012-2017)
Figure Europe Viral Molecular Diagnostics Sales Market Share by Countries in 2016
Table Europe Viral Molecular Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Europe Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Europe Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Europe Viral Molecular Diagnostics Revenue Market Share by Countries in 2016
Figure Germany Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure France Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure UK Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Viral Molecular Diagnostics Sales (K Units) by Type (2012-2017)
Table Middle East Viral Molecular Diagnostics Market Share by Type (2012-2017)
Figure Middle East Viral Molecular Diagnostics Market Share by Type (2012-2017)
Table Middle East Viral Molecular Diagnostics Sales (K Units) by Applications (2012-2017)
Table Middle East Viral Molecular Diagnostics Market Share by Applications (2012-2017)
Figure Middle East Viral Molecular Diagnostics Sales Market Share by Application in 2016
Table Middle East Viral Molecular Diagnostics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Viral Molecular Diagnostics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Viral Molecular Diagnostics Sales Volume Market Share by Countries in 2016
Table Middle East Viral Molecular Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Middle East Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Middle East Viral Molecular Diagnostics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Viral Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Viral Molecular Diagnostics Sales (K Units) by Type (2012-2017)
Table Africa Viral Molecular Diagnostics Sales Market Share by Type (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales Market Share by Type (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales Market Share by Type in 2016
Table Africa Viral Molecular Diagnostics Sales (K Units) by Application (2012-2017)
Table Africa Viral Molecular Diagnostics Sales Market Share by Application (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales Market Share by Application (2012-2017)
Table Africa Viral Molecular Diagnostics Sales Volume (K Units) by Countries (2012-2017)
Table Africa Viral Molecular Diagnostics Sales Market Share by Countries (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales Market Share by Countries (2012-2017)
Figure Africa Viral Molecular Diagnostics Sales Market Share by Countries in 2016
Table Africa Viral Molecular Diagnostics Revenue (Million USD) by Countries (2012-2017)
Table Africa Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Africa Viral Molecular Diagnostics Revenue Market Share by Countries (2012-2017)
Figure Africa Viral Molecular Diagnostics Revenue Market Share by Countries in 2016
Figure South Africa Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Table Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Basic Information List
Table Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories, Inc.(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Bio-Rad Laboratories(US) Viral Molecular Diagnostics Basic Information List
Table Bio-Rad Laboratories(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Bio-Rad Laboratories(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Bio-Rad Laboratories(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Beckman Coulter(US) Viral Molecular Diagnostics Basic Information List
Table Beckman Coulter(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beckman Coulter(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Beckman Coulter(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Beckman Coulter(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Auto Genomics Inc(US) Viral Molecular Diagnostics Basic Information List
Table Auto Genomics Inc(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Auto Genomics Inc(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Auto Genomics Inc(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Auto Genomics Inc(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Becton, Dickinson and Company(US) Viral Molecular Diagnostics Basic Information List
Table Becton, Dickinson and Company(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Becton, Dickinson and Company(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Becton, Dickinson and Company(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Becton, Dickinson and Company(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Basic Information List
Table F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG(Swizerland) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Roche Diagnostics(US) Viral Molecular Diagnostics Basic Information List
Table Roche Diagnostics(US) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics(US) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Diagnostics(US) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Roche Diagnostics(US) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Olympus Corporation(Japan) Viral Molecular Diagnostics Basic Information List
Table Olympus Corporation(Japan) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Olympus Corporation(Japan) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Olympus Corporation(Japan) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Olympus Corporation(Japan) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table Sanofi(China) Viral Molecular Diagnostics Basic Information List
Table Sanofi(China) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi(China) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi(China) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure Sanofi(China) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table QIAGEN(Germany) Viral Molecular Diagnostics Basic Information List
Table QIAGEN(Germany) Viral Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QIAGEN(Germany) Viral Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2017)
Figure QIAGEN(Germany) Viral Molecular Diagnostics Sales Market Share in EMEA (2012-2017)
Figure QIAGEN(Germany) Viral Molecular Diagnostics Revenue Market Share in EMEA (2012-2017)
Table bioMerieux SA(France) Viral Molecular Diagnostics Basic Information List
Table Meridian Bioscience, Inc(US) Viral Molecular Diagnostics Basic Information List
Table Gen-Probe Inc.(US) Viral Molecular Diagnostics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Molecular Diagnostics
Figure Manufacturing Process Analysis of Viral Molecular Diagnostics
Figure Viral Molecular Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Viral Molecular Diagnostics Major Manufacturers in 2016
Table Major Buyers of Viral Molecular Diagnostics
Table Distributors/Traders List
Figure EMEA Viral Molecular Diagnostics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Viral Molecular Diagnostics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Viral Molecular Diagnostics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Viral Molecular Diagnostics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Viral Molecular Diagnostics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Viral Molecular Diagnostics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Viral Molecular Diagnostics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Viral Molecular Diagnostics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Viral Molecular Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Viral Molecular Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Viral Molecular Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Viral Molecular Diagnostics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Viral Molecular Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Viral Molecular Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Viral Molecular Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Viral Molecular Diagnostics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Viral Molecular Diagnostics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Viral Molecular Diagnostics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Viral Molecular Diagnostics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Viral Molecular Diagnostics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Viral Molecular Diagnostics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Viral Molecular Diagnostics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Viral Molecular Diagnostics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.